These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1536140)

  • 1. Low-dose cytosine arabinoside for treating hypocellular acute leukemia in the elderly.
    Kanamori H; Maruta A; Miyashita H; Harano H; Fukawa H; Matsuzaki M; Motomura S; Mohri H; Kodama F; Okubo T
    Am J Hematol; 1992 Jan; 39(1):52-5. PubMed ID: 1536140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients.
    Tilly H; Castaigne S; Bordessoule D; Sigaux F; Daniel MT; Monconduit M; Degos L
    Cancer; 1985 Apr; 55(8):1633-6. PubMed ID: 3978558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia.
    Winter JN; Variakojis D; Gaynor ER; Larson RA; Miller KB
    Cancer; 1985 Aug; 56(3):443-9. PubMed ID: 3859362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-dose cytarabine treatment in acute leukemias and leukemic meningiosis: clinical aspects and pharmacokinetics].
    Nowrousian MR; Seeber S; Miller AA; Anders C; Ohl S; Schmidt CG
    Onkologie; 1985 Feb; 8(1):26-32. PubMed ID: 3885117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromes.
    Aul C; Schneider W
    Cancer; 1989 Nov; 64(9):1812-8. PubMed ID: 2790694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-dose cytosine arabinoside in the treatment of elderly patients with acute leukemia and refractory anemia with excess of blast.
    Satou Y; Kubota T; Yonekura S; Noguchi K; Oobayashi Y; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1986 Oct; 11(4):249-54. PubMed ID: 3617109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose arabinosyl cytosine in acute leukemia after a myelodysplastic syndrome and in elderly leukemia.
    Alessandrino EP; Orlandi E; Brusamolino E; Lazzarino M; Bernasconi C
    Am J Hematol; 1985 Oct; 20(2):191-3. PubMed ID: 4036958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cytosine arabinoside maintenance in acute nonlymphoblastic leukemia.
    Grozea PN; Bottonley RH; Shaw MT; Tu H; Chanes RE; Condit PT
    Cancer; 1975 Sep; 36(3):855-60. PubMed ID: 1182675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
    Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose cytosine arabinoside in acute non-lymphoblastic leukemia.
    Kumar L; Kochupillai V; Dua H
    Cancer; 1989 Feb; 63(3):415-8. PubMed ID: 2912519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An attempt at synchronization of marrow cells in acute leukemia: relationship to therapeutic response.
    Kremer WB; Vogler WR; Chan YK
    Cancer; 1976 Jan; 37(1):390-403. PubMed ID: 1082365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6-thioguanine (NSC-752).
    Armitage JO; Burns CP
    Cancer Treat Rep; 1976 May; 60(5):585-9. PubMed ID: 991147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High-dose cytosine arabinoside treatment of leukemia with special reference to the optimal number of doses].
    Sampi K; Maseki N; Kumai R; Kaneko Y; Sakurai M; Hattori M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2595-8. PubMed ID: 2774589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.
    Herzig RH; Lazarus HM; Wolff SN; Phillips GL; Herzig GP
    J Clin Oncol; 1985 Jul; 3(7):992-7. PubMed ID: 3894588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis.
    Iacoboni SJ; Plunkett W; Kantarjian HM; Estey E; Keating MJ; McCredie KB; Freireich EJ
    J Clin Oncol; 1986 Jul; 4(7):1079-88. PubMed ID: 3459811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose cytosine arabinoside therapy for refractory leukemia.
    Herzig RH; Wolff SN; Lazarus HM; Phillips GL; Karanes C; Herzig GP
    Blood; 1983 Aug; 62(2):361-9. PubMed ID: 6223674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukaemia.
    Jensen MK; Ahlbom G
    Scand J Haematol; 1985 Mar; 34(3):261-3. PubMed ID: 3992192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of acute myeloblastic leukemia in elderly patients with low-dose cytosine arabinoside].
    Tilly H; Castaigne S; Sigaux F; Degos L
    Presse Med; 1985 Apr; 14(15):827-31. PubMed ID: 3158904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for acute non-lymphocytic leukemia with low-dose cytosine arabinoside (Ara-C).
    Lin SF; Liu HW; Chen TP
    Nihon Ketsueki Gakkai Zasshi; 1990 Feb; 53(1):45-50. PubMed ID: 2330805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction therapy of newly diagnosed acute nonlymphocytic leukemia with idarubicin and cytosine arabinoside--the Taiwan experience.
    Chen YC; Lin SF; Yao M; Chen TY; Tsao CJ; Chen TP
    Semin Hematol; 1996 Oct; 33(4 Suppl 3):30-4. PubMed ID: 8916314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.